Doose Sendromu (Miyoklonik-Astatik Epilepsi)
Özet
Doose sendromu, çocukluk çağında başlayan ve miyoklonik veya astatik nöbetlerle kendini gösteren nadir bir epileptik ensefalopatidir. Hastalık genellikle 7 ay ile 6 yaş arasında ortaya çıkar, çeşitli nöbet türlerini içerir ve tedaviye dirençli seyredebilir. Erken teşhis ve ketojenik diyet gibi yöntemlerin uygulanması, uzun vadeli nöbet kontrolü ve bilişsel prognoz üzerinde kritik bir öneme sahiptir.
Doose syndrome, also known as myoclonic-astatic epilepsy, is a rare childhood-onset epileptic encephalopathy characterized by myoclonic and astatic seizures. Onset typically occurs between 7 months and 6 years of age, and the condition presents with various seizure types that can be resistant to standard medication. Early diagnosis and therapeutic interventions, particularly the ketogenic diet, are crucial for improving long-term seizure control and cognitive outcomes.
Referanslar
Doose H, Gerken H, Leonhardt R, Vozke E, Volz C. Centrencephalic myoclonic-astatic petit mal. Clinical and genetic investigations Neuropediatrie. 1970;2:59-78
Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30:389-399.
Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005-2009. Epilepsia. 2010;51:676-685.
Mullen SA, Marini C, Suls A, et al. Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch Neurol. 2011;68:1152-1155.
Nickels K, Eric H. Kossoff, Eschbach K, Joshi C. Epilepsy with myoclonic-atonic seizures (Doose syndrome): Clarification of diagnosis and treatment options through a large retrospective multicenter cohort Epilepsia. 2020;00:1-8.
Kaminska A, Ickowicz A, Plouin P, Bru MF, Dellatolas G, Dulac O. Delineation of cryptogenic Lennox–Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res. 1999;36:15-29.
Oguni H, Fukuyama Y, Tanaka T, et al. Myoclonic-astatic epilepsy of early childhood-clinical and EEG analysis of myoclonic-astatic seizures, and discussions on the nosology of the syndrome. Brain Dev. 2001; 23:757-764.
Kilaru S, Bergqvist AGC. Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia. 2007;48:1703-1707.
Tang S, Pal DK. Dissecting the genetic basis of myoclonic-astatic epilepsy. Epilepsia. 2012;53:1303-1313.
Kelley SA, Kossoff EH. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol. 2010;52:988-993.
Ohtsuka Y, Yoshinaga H, Kobayashi K, Ogino T, Oka M, Ito M. Diagnostic issues and treatment of cryptogenic or symptomatic generalized epilepsies. Epilepsy Res. 2006;70:132-140.
Dulac O, N’Guyen T. The Lennox-Gastaut syndrome. Epilepsia. 1993;34(Suppl. 7):S7-S17.
Nabbout R, Kozlovski A, Gennaro E, et al. Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy. Epilepsy Res. 2003;56:127-133.
Doose H, Waltz S. Photosensitivity-genetics and clinical significance. Neuropediatrics. 1993;24:249-255.
Waltz S, Christen HJ, Doose H. The different patterns of the photoparoxysmal response-a genetic study. Electroencephalogr Clin Neurophysiol. 1992;83:138-145.
Engel J Jr. Report of the ILAE classification core group. Epilepsia. 2006;47:1558-1568
Stephani U. The natural history of myoclonic astatic epilepsy (Doose syndrome) and Lennox-Gastaut syndrome. Epilepsia. 2006;47:53-55.
Moeller F, Groening K, Moehring J, et al. EEG-fMRI in myoclonic astatic epilepsy (Doose syndrome) Neurology. 2014;82;1508-1513.
Millichap JJ, Koh S, Laux LC, Nordli DR. Child Neurology: A Case-Based Approach. Dravet syndrome. Nurology. 2009;73:e59-e62.
McTague A, Cross JH. Treatment of epileptic encephalopathies. CNS Drugs. 2013;27:175-84.
Wiemer-Kruel A, Haberlandt E, Hartmann H, Wohlrab G, Bast T. Modified Atkins diet is an effective treatment for children with Doose syndrome. Epilepsia. 2017;58:657-662.
Labate A, Colosimo E, Gambardella A, Leggio U, Ambrosia R, Quattrone A. Levetiracetam in patients with generalized epilepsy and myoclonic seizures: an open label study. Seizure. 2006;15:214-218.
Caraballo RH, Cerosimo RO, Sakr D, Cresta A, Escobal N, Fejerman N. Ketogenic diet in patients with myoclonic–astatic epilepsy. Epileptic Disorder. 2006;8:151-155.
Buoni S, Mariottini A, Pieri S, et al. Vagus nerve stimulation for drug-resistant epilepsy in children and young adults. Brain Dev. 2004;26:158-163.
Carvill G, McMahon J, Schneider A, et al. Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic-atonic seizures. Am J Hum Genet. 2015;96:808-815.
